Use of fall risk-increasing drugs in older adults with multiple myeloma: A cross-sectional study
Tài liệu tham khảo
Dempsey, 2019, The pharmacologic management of multiple myeloma in older adults, Expert Opin Pharmacother, 20, 887, 10.1080/14656566.2019.1577822
João, 2020, Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: deliberations and recommendations from an expert panel of hematologists, J Geriatr Oncol, 11, 1210, 10.1016/j.jgo.2020.06.002
Palumbo, 2015, Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international myeloma working group report, Blood, 125, 2068, 10.1182/blood-2014-12-615187
Kaweme, 2021, Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects, Front Med (Lausanne), 25
Schoenbeck, 2021, Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma, J Geriatr Oncol, 10.1016/j.jgo.2021.02.009
Wildes, 2018, Falls in older adults with multiple myeloma, Eur J Haematol [SL], 100, 273, 10.1111/ejh.13009
Wildes, 2021, 10, 3563
Covington, 2020, Understanding fall risk for older adults with cancer: an evaluation of experts perceptions, J Geriatr Oncol, 2, 263, 10.1016/j.jgo.2019.06.006
Hart, 2020, Use of fall risk–increasing drugs around a fall-related injury in older adults: a systematic review, J Am Geriatr Soc, s.l., 2645
Seppala, 2020, 249
Ward, 2014, Fall-related injuries in elderly cancer patients treated with neurotoxic chemotherapy: a retrospective cohort study, J Geriatr Oncol, 5, 57, 10.1016/j.jgo.2013.10.002
Morris, 2020, Falls and cancer, Clin Oncol, 10.1016/j.clon.2020.03.011
Umıt, 2019, Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, J Oncol Pharm Pract
Sattar, 2021, Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment, Support Care Cancer, 1, 21, 10.1007/s00520-020-05619-2
United Nations, Department of Economic and Social Affairs, Population Division, 2015
Beasley, 2009, Development and implementation of a pharmacy fall prevention program, Hosp Pharm, 44, 1095, 10.1310/hpj4412-1095
Yazdani, 2017, Evaluation of the “medication fall risk score”, Am J Health Syst Pharm, 74, 10.2146/ajhp150745
Agency for Healthcare Research and Quality (AHRQ), 2013
Vilholm, 2014, Drug-induced peripheral neuropathy, Basic Clin Pharmacol Toxicol [SL], 115, 185, 10.1111/bcpt.12261
Jones, 2019, Drug-induced peripheral neuropathy: a narrative review, Curr Clin Pharmacol [SL], 15, 38
Gnjidic, 2012, Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes, J Clin Epidemiol, 65, 989, 10.1016/j.jclinepi.2012.02.018
Reis, 2017, Factors associated with the use of potentially inappropriate medications by older adults with cancer, J Geriatr Oncol, 8, 303, 10.1016/j.jgo.2017.05.003
American Geriatrics Society, 2019, Updated AGS beers criteria® for potentially inappropriate medication use in older adults, J Am Geriatr Soc [SL], 67, 674, 10.1111/jgs.15767
Elias, 2019, The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events, Drugs, 79, 715, 10.1007/s40265-019-01110-3
Lewis, 2014, Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study, J Bone Miner Res, 11, 2489, 10.1002/jbmr.2279
Poly, 2019, Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies, Osteoporos Int, 1, 103, 10.1007/s00198-018-4788-y
Carrière, 2016, Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort, Osteoporos Int, 11, 3187, 10.1007/s00198-016-3667-7
Gebara, 2015, Cause or effect? Selective serotonin reuptake inhibitors and falls in older adults: a systematic review, Am J Geriatr Psychiatry, 23, 1016, 10.1016/j.jagp.2014.11.004
De Vries, 2018, Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs, J Am Med Dir Assoc, 19, 371.e1, 10.1016/j.jamda.2017.12.013
Dharmarajan, 2015, Tolerability of antihypertensive medications in older adults, Drug Aging [sl], 32, 773, 10.1007/s40266-015-0296-3
Molassiotis, 2019, Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy, Brain Behav, 9, 10.1002/brb3.1312
Sánchez-Barroso, 2019, Concomitant medications and risk of chemotherapy-induced peripheral neuropathy, Oncologist, 24, e784, 10.1634/theoncologist.2018-0418
Stein, 2021, Association between neuropathy and B-vitamins: a systematic review and meta⠰analysis, Eur J Neurol [SL], 28, 2054, 10.1111/ene.14786
Diamond, 2017, Managing multiple myeloma in elderly patients, Leukemia Lymphoma [SL], 59, 1300, 10.1080/10428194.2017.1365859
Zweegman, 2017, Elderly patients with multiple myeloma, Curr Opin Oncol, 29, 315, 10.1097/CCO.0000000000000395
Nightingale, 2017, Polypharmacy in older adults with cancer: evaluating polypharmacy as part of the geriatric assessment, Curr Geriatr Rep, 6, 219, 10.1007/s13670-017-0221-1
Nightingale, 2015, Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer, J Clin Oncol, 33, 1453, 10.1200/JCO.2014.58.7550
Kierner, 2015, Polypharmacy in the terminal stage of cancer, Support Care Cancer, 24, 2067, 10.1007/s00520-015-3007-z
Sharma, 2016, Polypharmacy and potentially inappropriate medication use in geriatric oncology, J Geriatr Oncol, 7, 346, 10.1016/j.jgo.2016.07.010
Turner, 2016, Polypharmacy cut-points in older people with cancer: how many medications are too many?, Support Care Cancer, 24, 1831, 10.1007/s00520-015-2970-8
Richardson, 2015, Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults, Age Ageing, 44, 90, 10.1093/ageing/afu141